Clinical Trial Update: Benzodiazepine Discontinuation in Opioid Agonist Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating benzodiazepine discontinuation in patients undergoing opioid agonist therapy for substance use disorders has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Substance Use Disorders

Snippet

Sponsor: Boston Medical Center | Conditions: Substance Use Disorders | Phase 2 | Status: COMPLETED | Results posted: 2022-02-11